Grown Rogue International (GRUSF) Consolidated Net Income (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Consolidated Net Income came in at -$2.2 million in Q1 2026, up 100.0% quarter-over-quarter from -$5914.4 billion in Q4 2025.

Grown Rogue International (GRUSF) Consolidated Net Income (2009 - 2026) Analysis & Trends

Grown Rogue International's Consolidated Net Income history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income changed N/A year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$3079.3 billion, a 51094289.44% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, changed N/A from the prior year.
  • Consolidated Net Income advanced to -$2.2 million in Q1 2026 per GRUSF's latest filing, from -$5914.4 billion in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $2835.1 billion in Q3 2025 and bottomed at -$5914.4 billion in Q4 2025.
  • The 5-year median for Consolidated Net Income is -$166840.8 (2022), against an average of -$256.6 billion.
  • Across the five-year window, Consolidated Net Income soared 115.61% in 2022 and soared 579639897.23% in 2025, its largest moves.
  • Year by year, Consolidated Net Income stood at $155441.0 in 2022, then tumbled by 1026.08% to -$1.4 million in 2023, then soared by 66.02% to -$489122.6 in 2024, then slumped by 1209191462.96% to -$5914.4 billion in 2025, then surged by 100.0% to -$2.2 million in 2026.
  • Per Business Quant, the three latest GRUSF Consolidated Net Income figures stand at -$2.2 million (Q1 2026), -$5914.4 billion (Q4 2025), and $2835.1 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -2.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.21 Mn
Dec 31, 2025 -5,914.43 Bn
Sep 30, 2025 2,835.15 Bn
Jun 30, 2025 1.42 Mn
Sep 30, 2024 -489,122.56
Jun 30, 2024 -5.54 Mn
Dec 31, 2023 -1.44 Mn
Oct 31, 2023 -1.48 Mn
Jul 31, 2023 258,840.92
Apr 30, 2023 411,979.00
Jan 31, 2023 592,537.00
Jan 31, 2022 155,441.00
Jul 31, 2021 715,532.00
Apr 30, 2021 -586,589.00
Jan 31, 2021 -995,593.00
Oct 31, 2020 -3.55 Mn
Jul 31, 2020 -695,963.00
Apr 30, 2020 -616,581.00
Jan 31, 2020 -285,648.00
Oct 31, 2019 -893,504.00